Pfizer Gets Closer to Customers
Executive Summary
Pfizer's decision to bypass UK wholesalers and go direct to pharmacies should ultimately give it better control over product discounting. Other manufacturers are watching closely, and not just in the UK.
You may also be interested in...
No Cure, No Pay: The Future of Drug Marketing?
For most other consumer goods, you'd expect to get your money back if the product didn't work. Not so for drugs, where many treatments don't work in at least a significant minority of patients--but payors and governments can't claim a refund. That may be about to change.
No Cure, No Pay: The Future of Drug Marketing?
For most other consumer goods, you'd expect to get your money back if the product didn't work. Not so for drugs, where many treatments don't work in at least a significant minority of patients--but payors and governments can't claim a refund. That may be about to change.
CEO Interview: AstraZeneca's David Brennan
David Brennan has sharpened AstraZeneca's therapeutic area focus and embraced external R&D. The next two years will determine whether the productivity drive is working--or if more radical change is needed.